Physician profile
Elizabeth B Hannigan
NPI 1417359696
$1,982.00
in general payments reported to CMS, 2019-2025
5 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Vision Therapy provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $100 · 2024: $1,579 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $975 · Food and Beverage: $887 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $974.95 |
| Food and Beverage | $887.05 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,551.89 | 2024-2025 | Acuvue |
| Glaukos Corporation | $150.00 | 2025 | Photrexa Viscous and Photrexa |
| Biotissue Holdings INC. | $100.03 | 2024 | |
| Oyster Point Pharma, INC. | $100.00 | 2022 | |
| Coopervision INC. | $80.08 | 2024-2025 | Misight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Hannigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.